Summary: This review presents a thorough investigation of the role of CD47 in gastrointestinal cancers. We performed a comprehensive. in-depth review of over 100 preclinical and clinical studies focused on inhibiting CD47. The research highlights the potential of targeted CD47 to enhance existing treatments by boosting the immune response to cancer cells. https://www.roneverhart.com/ATCF/